Cargando…
Of Drugs and Trypanosomatids: New Tools and Knowledge to Reduce Bottlenecks in Drug Discovery
Leishmaniasis (Leishmania species), sleeping sickness (Trypanosoma brucei), and Chagas disease (Trypanosoma cruzi) are devastating and globally spread diseases caused by trypanosomatid parasites. At present, drugs for treating trypanosomatid diseases are far from ideal due to host toxicity, elevated...
Autores principales: | Bhattacharya, Arijit, Corbeil, Audrey, do Monte-Neto, Rubens L., Fernandez-Prada, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397081/ https://www.ncbi.nlm.nih.gov/pubmed/32610603 http://dx.doi.org/10.3390/genes11070722 |
Ejemplares similares
-
Exploring direct and indirect targets of current antileishmanial drugs using a novel thermal proteomics profiling approach
por: Ibarra-Meneses, Ana Victoria, et al.
Publicado: (2022) -
Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery
por: Balaña-Fouce, Rafael, et al.
Publicado: (2014) -
Three different mutations in the DNA topoisomerase 1B in Leishmania infantum contribute to resistance to antitumor drug topotecan
por: Rosa-Teijeiro, Chloé, et al.
Publicado: (2021) -
Anti-trypanosomatid drug discovery: progress and challenges
por: De Rycker, Manu, et al.
Publicado: (2022) -
Drug resistance analysis by next generation sequencing in Leishmania
por: Leprohon, Philippe, et al.
Publicado: (2014)